Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001553350-17-001165
Filing Date
2017-11-03
Accepted
2017-11-03 16:46:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G l1cap_sc13g.htm SC 13G 31770
  Complete submission text file 0001553350-17-001165.txt   33313
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Subject) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87057 | Film No.: 171177084
SIC: 2834 Pharmaceutical Preparations

Mailing Address 161A SHEDDEN ROAD ONE ARTILLARY COURT P.O. BOX 10085 GRAND KAYMAN E9 KY1-1001
Business Address 161A SHEDDEN ROAD ONE ARTILLARY COURT P.O. BOX 10085 GRAND KAYMAN E9 KY1-1001 646-688-5654
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by) CIK: 0001702202 (see all company filings)

EIN.: 981241877 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G